These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9258656)

  • 21. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B.
    Boldog F; Gemmill RM; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov MR; Klinger H; Drabkin HA
    Hum Mol Genet; 1997 Feb; 6(2):193-203. PubMed ID: 9063739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines.
    Mao L; Fan YH; Lotan R; Hong WK
    Cancer Res; 1996 Nov; 56(22):5128-31. PubMed ID: 8912845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
    Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
    Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FHIT gene alterations in head and neck squamous cell carcinomas.
    Virgilio L; Shuster M; Gollin SM; Veronese ML; Ohta M; Huebner K; Croce CM
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9770-5. PubMed ID: 8790406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of aberrant FHIT transcripts in gastric adenocarcinomas.
    Lee SH; Kim CJ; Park HK; Koh JW; Cho MH; Baek MJ; Lee MS
    Exp Mol Med; 2001 Sep; 33(3):124-30. PubMed ID: 11642547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing, but not allelic loss, of the FHIT gene increases with development of lung cancer.
    Sato H; Hiyama K; Ishioka S; Maeda H; Yamakido M
    Int J Oncol; 1999 Jul; 15(1):81-8. PubMed ID: 10375597
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K
    Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic FHIT analysis in RER+ and RER- adenocarcinomas of the pancreas.
    Hilgers W; Groot Koerkamp B; Geradts J; Tang DJ; Yeo CJ; Hruban RH; Kern SE
    Genes Chromosomes Cancer; 2000 Mar; 27(3):239-43. PubMed ID: 10679912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The fragile histidine triad gene: a molecular link between cigarette smoking and cervical cancer.
    Holschneider CH; Baldwin RL; Tumber K; Aoyama C; Karlan BY
    Clin Cancer Res; 2005 Aug; 11(16):5756-63. PubMed ID: 16115913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines.
    Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R
    Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
    Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact.
    Wang L; Darling J; Zhang JS; Qian CP; Hartmann L; Conover C; Jenkins R; Smith DI
    Oncogene; 1998 Feb; 16(5):635-42. PubMed ID: 9482109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
    Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
    Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
    Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
    Gayther SA; Barski P; Batley SJ; Li L; de Foy KA; Cohen SN; Ponder BA; Caldas C
    Oncogene; 1997 Oct; 15(17):2119-26. PubMed ID: 9366528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FHIT gene in oral squamous cell carcinoma: allelic imbalance is frequent but cDNA aberrations are uncommon.
    Pateromichelakis S; Lee G; Langdon JD; Partridge M
    Oral Oncol; 2000 Mar; 36(2):180-8. PubMed ID: 10745170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck.
    Kisielewski AE; Xiao GH; Liu SC; Klein-Szanto AJ; Novara M; Sina J; Bleicher K; Yeung RS; Goodrow TL
    Oncogene; 1998 Jul; 17(1):83-91. PubMed ID: 9671317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.